Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.646,94
1,20%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ United Therapeutics Corporation (UTHR) United Therapeutics Corporation (UTHR) Notizie

United Therapeutics Corporation

UTHR
262,40
4,27 (1,65%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202412:30BWUnited Therapeutics Corporation Reports First Quarter 2024..
26/4/202420:02BWCORRECTING and REPLACING PHOTO United Therapeutics Announces..
24/4/202415:00BWUnited Therapeutics Announces World’s First Successful..
24/4/202413:00BWUnited Therapeutics Corporation to Report First Quarter 2024..
16/4/202413:00BWUnited Therapeutics to Feature Clinical Data Across its..
26/3/202412:00BWUnited Therapeutics Announces the First Comprehensive Review..
25/3/202412:00BWUnited Therapeutics Corporation Announces $1 Billion..
11/3/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:18EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202412:00BWUnited Therapeutics Corporation to Present at the Leerink..
04/3/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:50EDGAR2Form 144 - Report of proposed sale of securities
27/2/202412:03EDGAR2Form 8-K - Current report
27/2/202412:00BWUnited Therapeutics Corporation to Present at the TD Cowen..
26/2/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:08EDGAR2Form 144 - Report of proposed sale of securities
21/2/202412:05EDGAR2Form 8-K - Current report
21/2/202412:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202412:00BWUnited Therapeutics Corporation Reports Fourth Quarter and..
21/2/202411:55BWUnited Therapeutics Commences Litigation to Ensure Fairness..
15/2/202422:36EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202412:00BWUnited Therapeutics Corporation to Report Fourth Quarter and..
08/2/202412:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:29EDGAR2Form 144 - Report of proposed sale of securities
24/1/202415:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:12EDGAR2Form 144 - Report of proposed sale of securities
05/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:06EDGAR2Form 144 - Report of proposed sale of securities
29/12/202312:00BWUnited Therapeutics Corporation to Present at the 42nd..
26/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202315:51EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/12/202322:56EDGAR2Form 144 - Report of proposed sale of securities
20/12/202323:00EDGAR2Form 8-K - Current report
20/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:53EDGAR2Form 144 - Report of proposed sale of securities
18/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 260,33 Min: 255,93 Max: 262,51
Chiusura: 258,13

La tua Cronologia

NASDAQ
UTHR
United Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network